Thus, the NLRP3 inflammasome plays a central role in endothelial dysfunction in response to various stimuli and therefore blocking this inflammasome or its key effectors has shown promise for diabetic therapy. This evidence concerns the gene NLRP3 and endothelial dysfunction.